Literature DB >> 1349792

The synthesis and antineoplastic activity of 2'-deoxy-nucleoside-cyanoboranes in murine and human culture cells.

A Sood1, B F Spielvogel, B R Shaw, L D Carlton, B S Burnham, E S Hall, I H Hall.   

Abstract

The guanine, inosine, adenine and cytidine deoxyriboside cyanoboranes proved to be cytotoxic and possess in vivo antineoplastic activity against murine and human single cells and cultured cells derived from solid tumor lines. The agents preferentially inhibited DNA synthesis in Tmolt3 leukemic cells. The enzyme sites of drug inhibition of two active derivatives were DNA polymerase-alpha and de novo purine synthesis at the regulatory sites, PRPP amido transferase and IMP dehydrogenase. Moderate inhibition by the agents of TDP kinase and ribonucleoside reductase activities also occurred. Kinetic studies showed that IMP dehydrogenase activity was inhibited the earliest of all of the enzymes affected by the drugs. The d(ATP) pools were also reduced by drug treatment. DNA strand scission was evident after 24 hr incubation at 100 microM of drug. The 14C-cytidine-cyanoborane drug was rapidly taken up over 6 hr and most effective uptake was shown by rapidly dividing cells. The drug was bound to DNA, RNA and protein in Tmolt3 leukemic cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349792

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Base-boronated dinucleotides: synthesis and effect of N7-cyanoborane substitution on the base protons.

Authors:  A Hasan; H Li; J Tomasz; B R Shaw
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

2.  Lipid-lowering effects of ethyl 2-phenacyl-3-aryl-1H-pyrrole- 4-carboxylates in rodents.

Authors:  Justin M Holub; Kathy O'Toole-Colin; Adam Getzel; Anthony Argenti; Michael A Evans; Daniel C Smith; Gerard A Dalglish; Shahzad Rifat; Donna L Wilson; Brett M Taylor; Ulander Miott; Josephine Glersaye; Kam Suet Lam; Bryan J McCranor; Joshua D Berkowitz; Robert B Miller; John R Lukens; Keith Krumpe; John T Gupton; Bruce S Burnham
Journal:  Molecules       Date:  2004-02-28       Impact factor: 4.411

Review 3.  Antisense therapy in neurology.

Authors:  Joshua J A Lee; Toshifumi Yokota
Journal:  J Pers Med       Date:  2013-08-02

Review 4.  Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes.

Authors:  I H Hall; S Y Chen; K G Rajendran; A Sood; B F Spielvogel; J Shih
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.